VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
VisionHealth has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in February 2023.
VisionHealth's investors include Aescuvest, EISMEA, DB Specialty Invest.
VisionHealth is headquartered in Munich, Germany.
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
VisionHealth is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VisionHealth — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/visionhealth. Accessed September 30, 2026.
VCBacked. (2023). VisionHealth — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/visionhealth
{{cite web |title=VisionHealth — Funding & Investors |url=https://www.vcbacked.co/company/visionhealth |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated